The University of Florida’s Prometheon Pharma has launched a million-dollar Indiegogo campaign to advance development of its groundbreaking needle-free, temperature stable insulin patches.
Needle-free patches developed by former faculty at UF and Harvard Medical School, Stephen Hsu, MD-PhD, Prometheon Pharma will replace billions of painful needle injections every year.
These patches are designed to improve the lives of patients around the world with Type I and Type II diabetes as well as those who are pre-diabetic. Besides this, these patches also reduce the burden of healthcare costs.
These patches are easy to develop and require low manufacturing cost. These patches are easy to store and no cold storages are required thus benefitting rural and impoverished populations equally.
Prometheon Pharma’s patch will continuously and consistently deliver insulin for up to 7 days. This can be replaced at any time according to user lifestyle and convenience.
Compared to oral, inhaled, or injected insulin delivery, insulin delivery with this patch is relatively easier to stop, when needed. Prometheon plans to have the patch available to patients by 2018.
